OA
Orbis Allan Gray Ltd
Orbis Allan Gray Ltd · Investor
1Y performance ⓘ
+24%
AUM (13F)
$23.7B
# of Holdings
91
3Y performance ⓘ
+60%
vs S&P 500 ⓘ
−4%
Updated
Mar 31
Orbis Allan Gray Ltd's Orbis Allan Gray Ltd holds 91 U.S.-equity positions worth $23.7B (SEC 13F, Q1 2026). Top positions: Corpay, Inc. 6.6%, QXO, Inc. 6.1%, Nebius Group N.V. Class A Ordinary Shares 3.6%. 13F-replication return is +60% over 3 years (-4 pts vs the S&P 500) — a replicated, non-audited figure.
Holdings
| Stock | % of portfolio | Shares | Value | Latest activity | Avg buy price | Current price | Date |
|---|---|---|---|---|---|---|---|
| CPAY Corpay, Inc. | 6.6% | 5.3M | $1.6B | ▲ 7.2% (+357K) | $305.64 | $382.11 (+25%) | 2026-03-31 |
| QXO QXO, Inc. | 6.1% | 74.0M | $1.4B | ▼ 13% (−11.5M) | $15.77 | $13.30 (−16%) | 2026-03-31 |
| NBIS Nebius Group N.V. Class A Ordinary Shares | 3.6% | 8.3M | $863M | ▲ 149% (+5.0M) | $74.47 | $190.41 (+156%) | 2026-03-31 |
| MSI Motorola Solutions, Inc. New | 3.4% | 1.9M | $811M | ▲ 46% (+587K) | $409.71 | $435.75 (+6%) | 2026-03-31 |
| PRAX Praxis Precision Medicines, Inc. Common Stock | 3.4% | 2.5M | $797M | ▲ 97% (+1.2M) | $308.25 | $307.83 (−0%) | 2026-03-31 |
| EQT EQT CORP | 3.2% | 12.1M | $771M | ▲ 248% (+8.6M) | $60.76 | $53.29 (−12%) | 2026-03-31 |
| GOOGL Alphabet Inc. Class A Common Stock | 3.0% | 2.5M | $723M | ▼ 5.7% (−151K) | $240.08 | $356.13 (+48%) | 2026-03-31 |
| GXO GXO Logistics, Inc. | 2.9% | 13.4M | $696M | — | $49.83 | $50.16 (+1%) | 2026-03-31 |
| XPO XPO, Inc. | 2.8% | 3.4M | $663M | ▼ 6.7% (−243K) | $57.91 | $200.97 (+247%) | 2026-03-31 |
| BRKR Bruker Corporation | 2.7% | 17.9M | $648M | ▲ 20% (+3.0M) | $36.00 | $62.84 (+75%) | 2026-03-31 |
| WLK Westlake Corporation | 2.6% | 5.3M | $618M | ▲ 21% (+907K) | $85.93 | $70.50 (−18%) | 2026-03-31 |
| ITUB Itau Unibanco Hldg S A | 2.5% | 69.3M | $580M | ▼ 15% (−12.4M) | $5.91 | $8.46 (+43%) | 2026-03-31 |
| STE STERIS plc | 2.4% | 2.6M | $573M | ▲ 15% (+343K) | $230.31 | $228.40 (−1%) | 2026-03-31 |
| NEM Newmont Corporation | 2.4% | 5.2M | $560M | ▼ 18% (−1.2M) | $55.49 | $93.71 (+69%) | 2026-03-31 |
| FSV FirstService Corporation Common Shares | 2.3% | 4.0M | $551M | ▲ 100% (+2.0M) | $153.95 | $140.89 (−8%) | 2026-03-31 |
| SW Smurfit Westrock plc | 2.3% | 13.8M | $549M | ▼ 1.3% (−182K) | $46.78 | $45.97 (−2%) | 2026-03-31 |
| RXO RXO, Inc. | 2.2% | 36.4M | $532M | ▲ 5.0% (+1.7M) | $21.61 | $20.25 (−6%) | 2026-03-31 |
| BTI British Amern Tob Plc | 1.9% | 7.7M | $451M | ▼ 17% (−1.6M) | $36.88 | $60.65 (+64%) | 2026-03-31 |
| ALNY Alnylam Pharmaceuticals, Inc. | 1.9% | 1.3M | $442M | ▼ 18% (−283K) | $270.45 | $205.52 (−24%) | 2026-03-31 |
| CNK Cinemark Holdings, Inc. | 1.8% | 15.1M | $429M | — | $18.19 | $36.59 (+101%) | 2026-03-31 |
| CX Cemex Sa Euro Mtn Be 144a | 1.8% | 37.1M | $425M | ▲ 2.8% (+1.0M) | $7.19 | $11.82 (+64%) | 2026-03-31 |
| IBKR Interactive Brokers Group, Inc. Class A Common Stock | 1.7% | 6.1M | $410M | ▼ 34% (−3.2M) | $20.66 | $87.99 (+326%) | 2026-03-31 |
| NTES Netease Com Inc | 1.7% | 3.6M | $401M | ▲ 5.8% (+195K) | $101.59 | $133.27 (+31%) | 2026-03-31 |
| SHEL Shell Plc | 1.6% | 4.1M | $383M | ▲ 179% (+2.6M) | $82.02 | $91.98 (+12%) | 2026-03-31 |
| KMI Kinder Morgan, Inc. | 1.6% | 11.3M | $379M | ▲ 7.2% (+758K) | $22.56 | $32.18 (+43%) | 2026-03-31 |
| NVDA NVIDIA CORP | 1.5% | 2.1M | $364M | NEW (+2.1M) | $174.40 | $200.75 (+15%) | 2026-03-31 |
| DIS The Walt Disney Company | 1.5% | 3.7M | $360M | ▲ 4.8% (+172K) | $91.78 | $96.19 (+5%) | 2026-03-31 |
| GMAB Genmab A/s | 1.5% | 12.9M | $347M | ▼ 10% (−1.5M) | $25.43 | $28.87 (+14%) | 2026-03-31 |
| BKNG Booking Holdings Inc. Common Stock | 1.3% | 74K | $311M | ▲ 140% (+43K) | $151.35 | $192.90 (+27%) | 2026-03-31 |
| VALE Vale S A | 1.3% | 19.4M | $308M | ▲ 6.2% (+1.1M) | $12.54 | $15.06 (+20%) | 2026-03-31 |
| INSM Insmed, Inc. | 1.3% | 1.9M | $306M | ▼ 55% (−2.3M) | $134.87 | $98.60 (−27%) | 2026-03-31 |
| CRSP CRISPR Therapeutics AG | 1.2% | 6.1M | $290M | ▲ 2.6% (+156K) | $52.64 | $47.99 (−9%) | 2026-03-31 |
| DEO Diageo Plc | 1.2% | 3.7M | $275M | ▲ 113% (+2.0M) | $89.59 | $88.06 (−2%) | 2026-03-31 |
| FNV Franco-Nevada Corporation | 1.1% | 1.1M | $267M | ▼ 23% (−330K) | $118.84 | $212.92 (+79%) | 2026-03-31 |
| B Barrick Mining Corporation | 1.0% | 6.0M | $246M | ▼ 9.9% (−662K) | $21.70 | $36.73 (+69%) | 2026-03-31 |
| AR ANTERO RESOURCES CORPORATION | 0.9% | 4.9M | $207M | ▲ 555% (+4.1M) | $41.22 | $36.14 (−12%) | 2026-03-31 |
| SRRK Scholar Rock Holding Corporation Common Stock | 0.9% | 4.2M | $205M | ▲ 22% (+751K) | $44.48 | $47.30 (+6%) | 2026-03-31 |
| GLD Spdr Gold Tr | 0.9% | 474K | $204M | ▼ 9.5% (−50K) | $187.16 | $371.54 (+99%) | 2026-03-31 |
| TBBB BBB Foods Inc. | 0.8% | 5.6M | $200M | ▲ 72% (+2.4M) | $34.22 | $41.33 (+21%) | 2026-03-31 |
| IMAX Imax Corp | 0.8% | 5.2M | $196M | — | $21.35 | $47.84 (+124%) | 2026-03-31 |
| RNR RenaissanceRe Holdings Ltd. | 0.8% | 648K | $193M | ▲ 2.1% (+14K) | $206.43 | $319.98 (+55%) | 2026-03-31 |
| RHI Robert Half Inc. | 0.8% | 7.5M | $192M | NEW (+7.5M) | $25.40 | $37.80 (+49%) | 2026-03-31 |
| PDD Pdd Holdings Inc | 0.8% | 1.7M | $178M | ▲ 49% (+576K) | $110.24 | $88.56 (−20%) | 2026-03-31 |
| AES AES Corporation | 0.7% | 12.2M | $173M | ▼ 43% (−9.1M) | $20.70 | $14.68 (−29%) | 2026-03-31 |
| SE Sea Ltd | 0.6% | 1.8M | $153M | ▼ 32% (−872K) | $156.28 | $106.74 (−32%) | 2026-03-31 |
| CRC California Resources Corporation | 0.6% | 2.2M | $151M | ▲ 13% (+251K) | $47.74 | $52.62 (+10%) | 2026-03-31 |
| R Ryder System, Inc. | 0.6% | 712K | $146M | ▼ 27% (−263K) | $173.45 | $256.42 (+48%) | 2026-03-31 |
| EAT Brinker International, Inc. | 0.6% | 928K | $132M | NEW (+928K) | $142.77 | $213.70 (+50%) | 2026-03-31 |
| DYN Dyne Therapeutics, Inc. Common Stock | 0.5% | 6.8M | $123M | ▲ 41% (+2.0M) | $19.15 | $25.18 (+32%) | 2026-03-31 |
| RRC Range Resources Corp | 0.5% | 2.7M | $122M | NEW (+2.7M) | $45.18 | $40.14 (−11%) | 2026-03-31 |
Showing top 50 of 91 holdings by value.
FAQ ▾
What are Orbis Allan Gray Ltd's largest holdings?
As of the latest 13F: Corpay, Inc. 6.6%, QXO, Inc. 6.1%, Nebius Group N.V. Class A Ordinary Shares 3.6%, Motorola Solutions, Inc. New 3.4%, Praxis Precision Medicines, Inc. Common Stock 3.4%.
How big is Orbis Allan Gray Ltd's 13F portfolio?
$23.7B across 91 disclosed U.S.-equity positions.
What is Orbis Allan Gray Ltd's 3-year performance?
+60% (13F-replication, price return), -4 pts vs the S&P 500. Not an audited fund return.
Where does this data come from?
U.S. SEC Form 13F-HR institutional holdings filings.
Sourced from SEC Form 13F-HR filings · Not investment advice ▾
Data as of 2026-03-31 · Methodology
13F-replication (price return, filing-date based) — not an audited fund return.
Published by WealthFile · Not investment advice.
Latest activity = change vs. the prior 13F. Avg buy price = est. entry over the trailing 3 years (gain = vs. latest price). Returns are 13F-replication, not audited fund returns. Sourced from SEC 13F filings.